American Society of Hirudotherapy

An old controversy revisited-one versus two venous anastomoses in microvascular head and neck reconstruction using anterolateral thigh flap

Research article published in Microsurgery (2014)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Observational studyClinical LiteratureChen et al. · Microsurgery, 2014

Abstract

BACKGROUND: The necessity of a second venous anastomosis in free tissue transfer is controversial. We review a single surgeon's 8-year experience of head and neck reconstruction using free anterolateral flap reconstruction to assess the need for a second venous anastomosis. PATIENTS AND METHOD: Three hundred and fifteen cases were included in the study after selecting only for anterolateral thigh flap, head, and neck reconstruction, and those that used superior thyroid artery as recipient. The selection criteria were designed to create as homogeneous a group as possible to decrease confounding factors. RESULTS: The group with single anastomosis required more frequent take-backs than the group with dual anastomoses (19% vs 10.8%, P = 0.055). The trend persisted when only take-backs for venous insufficiencies were compared (8.2% vs 2.5%, P = 0.039). When flaps with single anastomosis developed venous congestion, they were more likely to require operative salvage for venous insufficiency than those with dual anastomoses (35.5% vs. 6.3%, P = 0.037). No difference was found in postoperative complications and flap survival. CONCLUSION: Our data suggest that flaps with single venous anastomosis are more likely to require take-back for flap salvage than those with dual anastomoses.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsAdultAnastomosis, SurgicalFemaleFree Tissue FlapsHumansMaleMiddle AgedPostoperative ComplicationsPlastic Surgery ProceduresRetrospective StudiesTreatment OutcomeVenous Insufficiency

Summary

In 315 head and neck reconstructions with anterolateral thigh flaps, single venous anastomoses required take-backs more often (19% versus 10.8%) and more operative salvage for venous insufficiency, with no difference in flap survival.

Why This Matters for Hirudotherapy

This retrospective single-surgeon series of 315 anterolateral thigh free-flap head and neck reconstructions compared one versus two venous anastomoses, and found that flaps with a single venous anastomosis required take-backs more often (19% vs 10.8%) and, once venous congestion developed, were far more likely to need operative salvage for venous insufficiency (35.5% vs 6.3%), with no difference in overall flap survival. This matters to hirudotherapy because venous congestion of free flaps is precisely the clinical setting in which medicinal leeches are used adjunctively to decompress a struggling flap; the study quantifies how vulnerable single-outflow flaps are to exactly that complication. As an honest caveat, this is a retrospective observational study about anastomotic technique that does not study leech therapy itself, so it only frames the at-risk population rather than providing any direct evidence for leeching.

Citation

Reference (Vancouver style)

Chen WF, Kung YP, Kang YC, Lawrence WT, Tsao CK. An old controversy revisited-one versus two venous anastomoses in microvascular head and neck reconstruction using anterolateral thigh flap. Microsurgery. 2014;34(5):377-383. doi:10.1002/micr.22214. PMID: 24375807

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 28, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.